Manténgase sano!

Older Kids More Vulnerable to MIS-C: Study

Older Kids More Vulnerable to MIS-C: Study

Older children and teens are the most vulnerable to severe cases of a rare inflammatory disorder that can occur in youngsters who've had COVID-19, a new study finds.

It included 232 children aged 18 and younger who were admitted to 15 hospitals in Canada, Costa Rica and Iran with suspected multi-system inflammatory syndrome (MIS-C) between March 1, 2020, and March 7, 2021.

The World Health Organization's definition for MIS-C includes: fever that lasts for at least three days; elevated C-reactive protein, which indicates inflammation; illness involving two or more systems with no obvious microbial cause of inflammation, and a positive COVID test or suspected contact with a positive case.

Most of the patients in the study (89%) had gastrointestinal symptoms such as pain, and skin problems like rashes and swelling (85%). Heart involvement was common (59%), as were clotting abnormalities (90%).

Of the 232 children, 73 (31.5%) were admitted to ICU, and 64% needed treatment for very low blood pressure. The risk of admission to the ICU was higher in children ages 6 to 12 years (44%) and 13 to 17 years (46%) than in children ages 5 and under (18%).

Children admitted to the hospital later in the pandemic (between November 2020 and March 2021) were more likely to be admitted to the ICU (50 of 112 or 45%) than those hospitalized earlier (23 of 120, 19%).

The researchers also found that those patients with high blood markers for inflammation had a higher risk of severe MIS-C.

The study was published April 11 in the Canadian Medical Association Journal.

Diagnosing MIS-C can be challenging, the researchers noted.

"Multi-system inflammatory syndrome in children is a new diagnosis, with differing diagnostic criteria that have not been validated," Dr. Joan Robinson, a pediatrician at the University of Alberta in Edmonton, Canada, and co-authors wrote.

"Most of these children lacked a history of contact with a person with proven SARS-CoV-2 infection. Identifying exposure can be difficult as infected contacts may be asymptomatic or may never have been tested," they said in a journal news release.

International consensus on MIS-C diagnostic criteria is needed to improve clinical care and research, the study authors stressed.

More information

There's more on MIS-C at the U.S. Centers for Disease Control and Prevention.

SOURCE: Canadian Medical Association Journal, news release, April 11, 2022

HealthDay
El servicio de noticias de salud es un servicio para los usuarios de la página web de Champion Discount Pharmacy gracias a HealthDay. Champion Discount Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.
Derechos de autor © 2024 HealthDay Reservados todos los derechos.